AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CVS GROUP PLC

Transaction in Own Shares Nov 18, 2025

7590_pos_2025-11-18_4ba12dc7-4ef7-457d-ada0-e5559a88c396.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8809H

CVS Group plc

18 November 2025

18 November 2025

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

CVS announces that on 17 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

Date of purchase: 17/11/2025
Aggregate number of Ordinary Shares purchased: 26,379
Lowest price paid per share (GBp): 1,130.00
Highest price paid per share (GBp): 1,144.00
Volume weighted average price paid per share (GBp): 1,136.95

CVS intends to cancel all of the purchased Ordinary Shares.

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,290,112 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

The total number of voting rights in CVS is therefore 71,290,112 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Since the commencement of the Share Buyback Programme, the Company has repurchased 450,671 Ordinary Shares in aggregate at a weighted average price of 1,238.57 pence per share.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

Individual transactions:

Number of

Ordinary Shares purchased
Transaction price (GBp share) Time of

transaction (UK Time)
Transaction

reference number
Trading Venue
184 1140 17/11/2025 08:09:38 1334764783014121 XLON
430 1142 17/11/2025 09:05:20 1334764783020455 XLON
24 1140 17/11/2025 09:19:44 1334764783021518 XLON
49 1140 17/11/2025 09:19:44 1334764783021519 XLON
72 1140 17/11/2025 09:19:44 1334764783021520 XLON
69 1140 17/11/2025 09:19:44 1334764783021521 XLON
16 1140 17/11/2025 09:19:44 1334764783021522 XLON
698 1144 17/11/2025 10:14:06 1334764783025918 XLON
149 1144 17/11/2025 10:14:06 1334764783025919 XLON
76 1142 17/11/2025 10:26:43 1334764783026875 XLON
84 1142 17/11/2025 10:31:37 1334764783027404 XLON
489 1144 17/11/2025 10:40:23 1334764783028517 XLON
244 1144 17/11/2025 10:40:23 1334764783028518 XLON
817 1144 17/11/2025 10:48:52 1334764783029342 XLON
165 1144 17/11/2025 10:48:52 1334764783029343 XLON
432 1142 17/11/2025 10:51:30 1334764783029559 XLON
592 1142 17/11/2025 11:39:29 1334764783033730 XLON
89 1142 17/11/2025 11:39:29 1334764783033732 XLON
284 1142 17/11/2025 12:26:19 1334764783036985 XLON
16 1142 17/11/2025 12:26:19 1334764783036986 XLON
113 1142 17/11/2025 12:26:19 1334764783036989 XLON
561 1138 17/11/2025 12:40:36 1334764783037836 XLON
507 1138 17/11/2025 12:40:36 1334764783037837 XLON
76 1136 17/11/2025 13:10:10 1334764783040804 XLON
116 1136 17/11/2025 13:14:41 1334764783041124 XLON
991 1136 17/11/2025 13:14:41 1334764783041125 XLON
190 1138 17/11/2025 13:35:41 1334764783042857 XLON
937 1138 17/11/2025 13:51:08 1334764783044144 XLON
190 1138 17/11/2025 13:51:08 1334764783044147 XLON
190 1138 17/11/2025 13:51:08 1334764783044150 XLON
1609 1138 17/11/2025 13:51:08 1334764783044151 XLON
190 1138 17/11/2025 13:51:08 1334764783044152 XLON
190 1138 17/11/2025 13:51:08 1334764783044153 XLON
190 1138 17/11/2025 13:51:08 1334764783044154 XLON
190 1138 17/11/2025 13:51:08 1334764783044155 XLON
190 1138 17/11/2025 13:51:08 1334764783044156 XLON
190 1138 17/11/2025 13:51:08 1334764783044157 XLON
190 1138 17/11/2025 13:51:08 1334764783044158 XLON
190 1138 17/11/2025 13:51:08 1334764783044159 XLON
190 1138 17/11/2025 13:51:08 1334764783044160 XLON
617 1138 17/11/2025 13:51:08 1334764783044161 XLON
190 1138 17/11/2025 13:51:08 1334764783044162 XLON
110 1138 17/11/2025 13:51:08 1334764783044163 XLON
194 1138 17/11/2025 13:51:08 1334764783044164 XLON
190 1138 17/11/2025 13:51:09 1334764783044174 XLON
289 1138 17/11/2025 13:51:09 1334764783044177 XLON
5 1138 17/11/2025 13:51:09 1334764783044178 XLON
185 1138 17/11/2025 13:51:10 1334764783044179 XLON
29 1138 17/11/2025 13:51:10 1334764783044180 XLON
18 1138 17/11/2025 13:51:11 1334764783044182 XLON
43 1138 17/11/2025 13:51:11 1334764783044183 XLON
22 1138 17/11/2025 13:51:11 1334764783044184 XLON
18 1138 17/11/2025 13:51:11 1334764783044185 XLON
89 1138 17/11/2025 13:51:14 1334764783044186 XLON
42 1138 17/11/2025 13:51:14 1334764783044187 XLON
26 1138 17/11/2025 13:51:14 1334764783044189 XLON
164 1138 17/11/2025 13:51:16 1334764783044198 XLON
18 1138 17/11/2025 13:51:17 1334764783044200 XLON
172 1138 17/11/2025 13:51:19 1334764783044201 XLON
1994 1138 17/11/2025 13:51:19 1334764783044203 XLON
76 1136 17/11/2025 13:51:19 1334764783044208 XLON
990 1134 17/11/2025 14:10:36 1334764783046019 XLON
374 1134 17/11/2025 14:10:36 1334764783046020 XLON
547 1132 17/11/2025 14:13:15 1334764783046452 XLON
835 1132 17/11/2025 14:13:15 1334764783046453 XLON
1402 1130 17/11/2025 14:15:27 1334764783046723 XLON
17 1130 17/11/2025 14:15:27 1334764783046726 XLON
867 1130 17/11/2025 14:15:27 1334764783046727 XLON
17 1130 17/11/2025 14:15:27 1334764783046725 XLON
500 1130 17/11/2025 14:15:27 1334764783046724 XLON
76 1132 17/11/2025 14:31:46 1334764783048637 XLON
219 1132 17/11/2025 14:32:00 1334764783048711 XLON
243 1132 17/11/2025 14:32:00 1334764783048712 XLON
76 1136 17/11/2025 14:42:37 1334764783051049 XLON
1412 1136 17/11/2025 14:48:43 1334764783052311 XLON
1165 1136 17/11/2025 14:48:43 1334764783052313 XLON
257 1132 17/11/2025 14:52:36 1334764783053251 XLON
85 1132 17/11/2025 14:52:36 1334764783053252 XLON
266 1130 17/11/2025 15:15:55 1334764783057961 XLON
295 1136 17/11/2025 15:17:21 1334764783058239 XLON
76 1134 17/11/2025 15:17:30 1334764783058266 XLON

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                 +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

Camarco (Financial PR)                                                                                                                             [email protected]

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSGPGWWGUPAGRM

Talk to a Data Expert

Have a question? We'll get back to you promptly.